应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01066 威高股份
劳动节休市 04-30 16:08:13
3.440
-0.110
-3.10%
最高
3.530
最低
3.420
成交量
6,103万
今开
3.530
昨收
3.550
日振幅
3.10%
总市值
155.38亿
流通市值
153.73亿
总股本
45.17亿
成交额
2.10亿
换手率
1.37%
流通股本
44.69亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
威高股份(01066)拟设立基金投资于韩国及海外的中小型企业与中型企业
智通财经 · 04-30 22:18
威高股份(01066)拟设立基金投资于韩国及海外的中小型企业与中型企业
威高股份子公司拟与维高(香港)等共同设立基金 规模达529.65亿韩元(约合2.44亿元人民币)
美股速递 · 04-30 22:08
威高股份子公司拟与维高(香港)等共同设立基金 规模达529.65亿韩元(约合2.44亿元人民币)
威高股份(01066.HK)4月30日耗资89.51万港元回购25.84万股
中金财经 · 04-30 17:37
威高股份(01066.HK)4月30日耗资89.51万港元回购25.84万股
威高股份4月30日回购25.84万股,耗资约89.51万港元
公告速递 · 04-30 17:17
威高股份4月30日回购25.84万股,耗资约89.51万港元
威高股份(01066)4月29日斥资46.69万港元回购13.2万股
智通财经 · 04-29 17:29
威高股份(01066)4月29日斥资46.69万港元回购13.2万股
威高股份2025年业绩:收入稳增2.3%,骨科与血液管理表现突出
公告速递 · 04-28 19:35
威高股份2025年业绩:收入稳增2.3%,骨科与血液管理表现突出
威高股份拟回购最多10%H股股份
公告速递 · 04-28 19:32
威高股份拟回购最多10%H股股份
威高股份回购54.00万股股份,涉资约190.98万港元
公告速递 · 04-28 17:07
威高股份回购54.00万股股份,涉资约190.98万港元
威高股份:4月27日回购14万股股份,涉资约50.26万港元
公告速递 · 04-27
威高股份:4月27日回购14万股股份,涉资约50.26万港元
威高股份(01066)4月27日斥资50.26万港元回购14万股
智通财经网 · 04-27
威高股份(01066)4月27日斥资50.26万港元回购14万股
高盛:内地CDMO板块稳健 看好药明康德(02359)、凯莱英(06821)等
智通财经 · 04-27
高盛:内地CDMO板块稳健 看好药明康德(02359)、凯莱英(06821)等
威高股份4月24日回购12万股股份,耗资约44.08万港元
公告速递 · 04-24
威高股份4月24日回购12万股股份,耗资约44.08万港元
威高股份(01066)4月24日斥资44.08万港元回购12万股
智通财经 · 04-24
威高股份(01066)4月24日斥资44.08万港元回购12万股
威高股份4月23日回购18万股股份,总额约64.96万港元
公告速递 · 04-23
威高股份4月23日回购18万股股份,总额约64.96万港元
威高股份回购16万股股份,耗资约57.62万港元
公告速递 · 04-22
威高股份回购16万股股份,耗资约57.62万港元
威高股份(01066)4月22日斥资57.62万港元回购16万股
智通财经 · 04-22
威高股份(01066)4月22日斥资57.62万港元回购16万股
Wellington Management Group LLP增持威高股份(01066)约811.35万股 每股作价约3.69港元
智通财经网 · 04-22
Wellington Management Group LLP增持威高股份(01066)约811.35万股 每股作价约3.69港元
威高股份(01066)4月21日斥资123.48万港元回购34万股
中金财经 · 04-21
威高股份(01066)4月21日斥资123.48万港元回购34万股
威高股份4月21日回购34万股股份,涉资约123.48万港元
公告速递 · 04-21
威高股份4月21日回购34万股股份,涉资约123.48万港元
【券商聚焦】中信建投:医疗器械板块拐点来临 26年业绩改善个股存在业绩估值修复机会
金吾财讯 · 04-21
【券商聚焦】中信建投:医疗器械板块拐点来临 26年业绩改善个股存在业绩估值修复机会
加载更多
公司概况
公司名称:
威高股份
所属市场:
SEHK
上市日期:
--
主营业务:
山东威高集团医用高分子制品股份有限公司是一家主要从事研发、生产及销售医疗器械产品的中国公司。该公司通过六个分部运营业务。医疗器械产品分部生产及销售临床护理、医学检验、麻醉及手术相关产品以及其他耗材。骨科产品分部生产及销售骨科产品(包括组织修复产品线)。介入产品分部生产及销售肿瘤及血管介入器械。药品包装产品分部生产及销售预充式注射器及冲管注射器。血液管理产品分部生产及销售血液採集、辐射、贮存、分离及灭菌消毒产品。其他分部从事融资租赁及保理业务。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01066","market":"HK","secType":"STK","nameCN":"威高股份","latestPrice":3.44,"timestamp":1777536493003,"preClose":3.55,"halted":0,"volume":61026449,"delay":0,"changeRate":-0.030985915492957712,"floatShares":4469000000,"shares":4517000000,"eps":0.40696851172664467,"marketStatus":"劳动节休市","change":-0.11,"latestTime":"04-30 16:08:13","open":3.53,"high":3.53,"low":3.42,"amount":210196067,"amplitude":0.030986,"askPrice":3.45,"askSize":2000,"bidPrice":3.44,"bidSize":2200800,"shortable":3,"etf":0,"ttmEps":0.40696851172664467,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":7,"adr":0,"listingDate":1077811200000,"exchange":"SEHK","adjPreClose":3.55,"dividendRate":0.052281,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":3.1594425223958433,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01066","defaultTab":"news","newsList":[{"id":"2631568916","title":"威高股份(01066)拟设立基金投资于韩国及海外的中小型企业与中型企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2631568916","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631568916?lang=zh_cn&edition=full","pubTime":"2026-04-30 22:18","pubTimestamp":1777558731,"startTime":"0","endTime":"0","summary":"智通财经APP讯,威高股份 发布公告,于2026年4月30日,公司间接全资附属公司Wego Healthcare Fund 已与威高(香港)订立有限合伙协议,内容有关设立拟定规模为529.65亿韩元的基金,基金将主要投资于韩国及海外的中小型企业与中型企业,重点关注涉及韩国及海外企业、大学及研究机构的开放式创新与海外业务扩张领域。此外,基金投资约一半投向韩国、一半投向其他海外地区,有助分散单一市场周期波动风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437550.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","BK1589","LU0287142896.SGD","LU0173614495.USD","01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112937189","title":"威高股份子公司拟与维高(香港)等共同设立基金 规模达529.65亿韩元(约合2.44亿元人民币)","url":"https://stock-news.laohu8.com/highlight/detail?id=1112937189","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112937189?lang=zh_cn&edition=full","pubTime":"2026-04-30 22:08","pubTimestamp":1777558094,"startTime":"0","endTime":"0","summary":"山东威高集团医用高分子制品股份有限公司(简称威高股份)宣布,其子公司将联合维高(香港)及其他合作方,共同组建一支规模达529.65亿韩元(折合人民币约2.44亿元)的基金。该基金旨在通过资本运作推动医疗健康领域的战略布局,深化产业资源整合。此次合作彰显了威高股份在拓展国际业务、强化产业链协同方面的持续努力,也为企业未来增长注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066","BK1222","LU0173614495.USD","LU0287142896.SGD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631684205","title":"威高股份(01066.HK)4月30日耗资89.51万港元回购25.84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631684205","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631684205?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:37","pubTimestamp":1777541824,"startTime":"0","endTime":"0","summary":"格隆汇4月30日丨威高股份(01066.HK)发布公告,2026年4月30日耗资89.51万港元回购25.84万股,回购价格每股3.42-3.52港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260430/32194362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0287142896.SGD","01066","LU0173614495.USD","BK1222","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135537129","title":"威高股份4月30日回购25.84万股,耗资约89.51万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135537129","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135537129?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:17","pubTimestamp":1777540678,"startTime":"0","endTime":"0","summary":"威高股份于2026年4月30日披露回购公告,指公司当日在香港联交所场内回购H股25.84万股,回购股份占当日前已发行股份总数的约0.0058%。回购价格介乎每股3.42港元至3.52港元,平均每股购回价3.4641港元,涉及总金额约89.51万港元。本次回购后,公司非库存股份数目变动为44.68516324亿股,库存股份数目增至5381.6万股,已发行股份总数仍为45.22332324亿股。公司确认已遵守香港联交所相关上市规则及适用法律法规。该公司董事会于2025年5月27日通过股份回购授权,授权可回购4.51560392亿股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份4月30日回购25.84万股,耗资约89.51万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631930515","title":"威高股份(01066)4月29日斥资46.69万港元回购13.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631930515","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631930515?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:29","pubTimestamp":1777454954,"startTime":"0","endTime":"0","summary":"智通财经APP讯,威高股份(01066)发布公告,于2026年4月29日斥资46.69万港元回购13.2万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"375a71b8e97f2124ccebf58fbda10fa9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0287142896.SGD","01066","BK1589","LU0173614495.USD","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195025458","title":"威高股份2025年业绩:收入稳增2.3%,骨科与血液管理表现突出","url":"https://stock-news.laohu8.com/highlight/detail?id=1195025458","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195025458?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:35","pubTimestamp":1777376102,"startTime":"0","endTime":"0","summary":"山东威高集团医用高分子制品股份有限公司在2025年度实现收入人民币133.89亿元,同比增长2.3%。公司当年净利润为人民币17.11亿元,较上年度下降20.9%,主要受部分医用耗材降价、销售模式转型及宏观环境压力影响。归属于本公司拥有人的溢利则录得人民币16.12亿元,同比下滑22.0%。整体而言,威高股份在2025年实现收入稳健增长,尽管行业面临集采和成本上涨等多重挑战,但公司骨科与血液管理两大板块展现出增长亮点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份2025年业绩:收入稳增2.3%,骨科与血液管理表现突出","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197348685","title":"威高股份拟回购最多10%H股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1197348685","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197348685?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:32","pubTimestamp":1777375958,"startTime":"0","endTime":"0","summary":"山东威高集团医用高分子制品股份有限公司,于香港联合交易所上市。公司最新公告显示,将寻求股东大会授权,拟回购不超过公司已发行H股总数10%的股份,即最多约4.47亿股。公司董事会指出,此项回购旨在提高股东回报和维护公司价值,认为符合公司及股东的整体最佳利益。过去十二个月,威高股份H股股价最高曾达7.22港元,最低为3.56港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份拟回购最多10%H股股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1167708161","title":"威高股份回购54.00万股股份,涉资约190.98万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167708161","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167708161?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:07","pubTimestamp":1777367246,"startTime":"0","endTime":"0","summary":"山东威高集团医用高分子制品股份有限公司于2026年4月28日公布翌日披露报表,披露其在香港联交所场内回购公司股份的主要信息。公告显示,企业于同日合共回购普通股H股54.00万股,占回购前已发行股本约0.0121%。本次回购的最高价格为每股3.58港元,最低价格为每股3.50港元,总金额约190.98万港元。完成此次回购后,威高股份已发行股本为4,468,906,724股,库存股份数量则增加至53,425,600股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份回购54.00万股股份,涉资约190.98万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193957610","title":"威高股份:4月27日回购14万股股份,涉资约50.26万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193957610","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193957610?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:01","pubTimestamp":1777284091,"startTime":"0","endTime":"0","summary":"山东威高集团医用高分子制品股份有限公司于2026年4月27日发布公告,披露公司在香港联交所场内回购股份事宜。公告日期为2026年4月27日。根据公告,公司当日回购14万股H股,占回购前公司已发行股份约0.0031%,每股价格介乎3.58港元至3.62港元,合计耗资约50.26万港元。回购完成后,公司已发行股份总数为4,469,446,724股,库藏股数增至52,885,600股。截至目前,公司已回购46,237,200股,占购回授权通过日已发行股份总数约10.2394%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份:4月27日回购14万股股份,涉资约50.26万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630079364","title":"威高股份(01066)4月27日斥资50.26万港元回购14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630079364","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630079364?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:57","pubTimestamp":1777283834,"startTime":"0","endTime":"0","summary":"威高股份(01066)发布公告,于2026年4月27日,该公司斥资50.26万港元回购14万股。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_49.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_49.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0287142896.SGD","BK1222","BK1589","01066","LU0173614495.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630364329","title":"高盛:内地CDMO板块稳健 看好药明康德(02359)、凯莱英(06821)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2630364329","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630364329?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:25","pubTimestamp":1777281907,"startTime":"0","endTime":"0","summary":"股份方面,该行对评级为“买入”的股份持更正面态度,包括药明康德 、凯莱英 、微创机器人 及精锋医疗 。另外,该行将爱康医疗 评级升至“买入”,反映其执行力重启、利润率改善及中期能见度更清晰,并将微泰医疗 升级至“中性”,因国内竞争影响优于预期,且有序达成2026年指引。前者受累于持续的VBP相关利润压力及短期增长乏力,后者收入加速回升但仍不明朗,上行空间有限。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1997244956.HKD","LU0348766576.USD","LU1934453819.USD","LU0456842615.SGD","02359","LU0173614495.USD","BK4139","06821","BK1141","LU0708995583.HKD","LU0287142896.SGD","LU1979443071.USD","BK1617","LU0320764599.SGD","LU2328871848.SGD","BK1583","02252","LU1997245094.SGD","BK0132","BK1576","BK0216","LU1046422090.SGD","002821","BK1222","LU2125910500.SGD","LU1328615791.USD","01789","BK1585","LU2045819591.USD","LU1969619763.USD","BK1191","LU1997245177.USD","LU2242644610.SGD","BK1100","CDMO","01066","02675","LU2488822045.USD","LU2495084118.USD","LU0052750758.USD","LU1808992512.USD","LU0348767384.USD","603259","BK1589","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186090380","title":"威高股份4月24日回购12万股股份,耗资约44.08万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186090380","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186090380?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:17","pubTimestamp":1777022241,"startTime":"0","endTime":"0","summary":"山东威高集团医用高分子制品股份有限公司于2026年4月24日公告,2026年4月24日在香港联交所场内回购股份12万股,约占该次交易前已发行股本的0.0027%。回购价格区间介乎每股3.60港元至3.71港元,合计耗资约44.08万港元。本次回购依据2025年5月27日通过的购回授权进行,该授权可购回股份总数为4.51560392亿股,截至目前公司已回购约4609.72万股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份4月24日回购12万股股份,耗资约44.08万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629811112","title":"威高股份(01066)4月24日斥资44.08万港元回购12万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629811112","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629811112?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:13","pubTimestamp":1777022028,"startTime":"0","endTime":"0","summary":"智通财经APP讯,威高股份(01066)发布公告,于2026年4月24日,该公司斥资44.08万港元回购12万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0287142896.SGD","LU0173614495.USD","BK1222","BK1589","01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122762886","title":"威高股份4月23日回购18万股股份,总额约64.96万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122762886","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122762886?lang=zh_cn&edition=full","pubTime":"2026-04-23 18:43","pubTimestamp":1776941025,"startTime":"0","endTime":"0","summary":"山东威高集团医用高分子制品股份有限公司于2026年4月23日公告回购180,000股股份,占当日现有已发行股本约0.004%。回购价格区间介乎每股3.59港元至3.62港元,合计耗资约64.96万港元。公告显示,在本次回购后,公司已发行股份总数维持4,522,332,324股,其中4,469,706,724股为流通股,52,625,600股为库藏股。公司声明已遵守香港联交所上市规则及相关法律法规办理本次回购事宜。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"威高股份4月23日回购18万股股份,总额约64.96万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173112957","title":"威高股份回购16万股股份,耗资约57.62万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173112957","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173112957?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:05","pubTimestamp":1776855955,"startTime":"0","endTime":"0","summary":"2026年4月22日,威高股份发布公告,披露于香港联交所场内回购股份事件。公司本次共回购16万股股份,占当时已发行股本约0.0036%。回购价格介乎每股3.59港元至3.61港元,合计耗资约57.62万港元。公司曾于2025年5月27日获股东大会授权可回购最多451,560,392股股份,截至本次回购后,累计回购数量为45,797,200股,约占授权总数的10.142%。公司同时确认已遵守香港联合交易所有限公司的上市规则及相关法律法规。本次公告由公司秘书黄妙玲签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份回购16万股股份,耗资约57.62万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629004885","title":"威高股份(01066)4月22日斥资57.62万港元回购16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629004885","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629004885?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:03","pubTimestamp":1776855788,"startTime":"0","endTime":"0","summary":"智通财经APP讯,威高股份(01066)发布公告,于2026年4月22日该公司斥资57.62万港元回购16万股,回购价格为每股3.59-3.61港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0287142896.SGD","01066","BK1589","BK1222","LU0173614495.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629046589","title":"Wellington Management Group LLP增持威高股份(01066)约811.35万股 每股作价约3.69港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629046589","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629046589?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:01","pubTimestamp":1776855671,"startTime":"0","endTime":"0","summary":"香港联交所最新数据显示,4月20日,Wellington Management Group LLP增持威高股份(01066)811.3468万股,每股作价3.6865港元,总金额约为2991.03万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260422/20260422190153_79335.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260422/20260422190153_79335.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0287142896.SGD","BK1589","01066","LU0173614495.USD","BK1222","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629087030","title":"威高股份(01066)4月21日斥资123.48万港元回购34万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629087030","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629087030?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:17","pubTimestamp":1776766624,"startTime":"0","endTime":"0","summary":"智通财经APP讯,威高股份(01066)发布公告,于2026年4月21日该公司斥资123.48万港元回购34万股,回购价格为每股3.61-3.67港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260421/32160499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0173614495.USD","LU0287142896.SGD","BK1589","01066","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145829773","title":"威高股份4月21日回购34万股股份,涉资约123.48万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145829773","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145829773?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:05","pubTimestamp":1776765909,"startTime":"0","endTime":"0","summary":"山东威高集团医用高分子制品股份有限公司于2026年4月21日公告,4月21日在香港联交所场内回购股份34万股,占公司当日已发行股本约0.0076%。本次回购每股价格介乎港币3.61元至3.67元,合计耗资约港币123.48万元。公司购回授权于2025年5月27日获得通过,授权可回购股数为4.51560392亿股,截至目前累计回购约4563.72万股,约占授权额度的10.11%。公司在公告中确认已遵守香港联交所上市规则及相关法律规定。公告由公司秘书黄妙玲签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"威高股份4月21日回购34万股股份,涉资约123.48万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629087757","title":"【券商聚焦】中信建投:医疗器械板块拐点来临 26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2629087757","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629087757?lang=zh_cn&edition=full","pubTime":"2026-04-21 09:19","pubTimestamp":1776734371,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研究认为,医疗器械板块拐点已经来临,26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道,以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股,未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979495","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","BK1591","BK1247","06826","BK0276","BK1502","BK1515","BK1585","BK1615","BK1574","02235","01302","00853","BK1600","09996","601066","BK1100","BK1142","02190","BK1161","BK1610","159883","01066","LU0287142896.SGD","BK1571","BK1189","02252","09997","00241","BK1593","BK1501","BK1617","BK1583","LU0173614495.USD","BK1584","BK1587","BK1589"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.weigaogroup.com","stockEarnings":[{"period":"1week","weight":-0.0523},{"period":"1month","weight":-0.0827},{"period":"3month","weight":-0.312},{"period":"6month","weight":-0.3665},{"period":"1year","weight":-0.3709},{"period":"ytd","weight":-0.3147}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0399},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.1653},{"period":"ytd","weight":0.0057}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"山东威高集团医用高分子制品股份有限公司是一家主要从事研发、生产及销售医疗器械产品的中国公司。该公司通过六个分部运营业务。医疗器械产品分部生产及销售临床护理、医学检验、麻醉及手术相关产品以及其他耗材。骨科产品分部生产及销售骨科产品(包括组织修复产品线)。介入产品分部生产及销售肿瘤及血管介入器械。药品包装产品分部生产及销售预充式注射器及冲管注射器。血液管理产品分部生产及销售血液採集、辐射、贮存、分离及灭菌消毒产品。其他分部从事融资租赁及保理业务。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.3125,"avgChangeRate":-0.047366},{"month":2,"riseRate":0.625,"avgChangeRate":0.012777},{"month":3,"riseRate":0.4375,"avgChangeRate":0.016503},{"month":4,"riseRate":0.625,"avgChangeRate":0.01633},{"month":5,"riseRate":0.333333,"avgChangeRate":0.018158},{"month":6,"riseRate":0.6,"avgChangeRate":0.000469},{"month":7,"riseRate":0.6,"avgChangeRate":0.00754},{"month":8,"riseRate":0.4375,"avgChangeRate":0.011373},{"month":9,"riseRate":0.4375,"avgChangeRate":0.009695},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.00777},{"month":11,"riseRate":0.625,"avgChangeRate":0.002331},{"month":12,"riseRate":0.4375,"avgChangeRate":-0.007325}],"exchange":"SEHK","name":"威高股份","nameEN":"WEIGAO GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"威高股份(01066)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供威高股份(01066)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"威高股份,01066,威高股份股票,威高股份股票老虎,威高股份股票老虎国际,威高股份行情,威高股份股票行情,威高股份股价,威高股份股市,威高股份股票价格,威高股份股票交易,威高股份股票购买,威高股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"威高股份(01066)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供威高股份(01066)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}